Venetoclax with high-dose methotrexate and rituximab seem effective and well-tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report

Clinical Case Reports
Guillaume BeziatLoïc Ysebaert

Abstract

Venetoclax with high-dose methotrexate and rituximab seem effective and safe to treat central nervous system involvement of chronic lymphocytic leukemia.

References

Sep 14, 2007·Clinical Neurology and Neurosurgery·C P E LangeCh J Vecht
Sep 15, 2014·BMC Research Notes·Simone Lima de SouzaMaria Helena Ornellas
Sep 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B EichhorstUNKNOWN ESMO Guidelines Committee
Dec 8, 2015·The New England Journal of Medicine·Andrew W RobertsJohn F Seymour
Nov 20, 2016·British Journal of Haematology·Anne WanquetTherese Aurran-Schleinitz
Mar 22, 2018·The New England Journal of Medicine·John F SeymourArnon P Kater

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
nucleic acid amplification

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.